3 results  1 of 1 

1 Cost-Effectiveness of Recombinant Tissue Plasminogen Activator in the Management of Acute Ischemic Stroke: A Systematic Review
Kee-Taig Jung, Dong Wook Shin, Kyung-Jin Lee, Myungju Oh
J Clin Neurol.2010;6(3):117-126.   Published online 2010 September 30     DOI: http://dx.doi.org/10.3988/jcn.2010.6.3.117
      
2 Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis in a Patient with Acute Ischemic Stroke Secondary to Aortic Dissection
Keun-Sik Hong, So-Young Park, Seon-Il Whang, So-Young Seo, Dong-Ha Lee, Han-Joon Kim, Joong-Yang Cho, Yong-Jin Cho, Woo-Ik Jang, Chang Young Kim
J Clin Neurol.2009;5(1):49-52.   Published online 2009 March 31     DOI: http://dx.doi.org/10.3988/jcn.2009.5.1.49
      
3 Life-Threatening Anaphylactoid Reaction in an Acute Ischemic Stroke Patient With Intravenous rt-PA Thrombolysis, Followed by Successful Intra-Arterial Thrombolysis
In-Serk Park, A-Hyun Cho, Seung-Jae Lee, Joong-Seok Kim, Kwang-Soo Lee, Yeong-In Kim
J Clin Neurol.2008;4(1):29-32.   Published online 2008 March 20     DOI: http://dx.doi.org/10.3988/jcn.2008.4.1.29
      

 1 of 1